Vitaxin, a humanized monoclonal antibody, inhibits alphaV/beta3 integrin in human RA synovial tissue engrafted into SCID mice.

被引：0
|
作者：
El-Gabalawy, HS
Hitchon, CA
Ma, GP
El-Gabalawy, NC
Bailey, JL
White, AM
Jones, RE
Lyttle, D
Davis, LS
机构：
[1] Univ Manitoba, Winnipeg, MB, Canada
[2] Univ Texas Dallas, Dallas, TX 75230 USA
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 5 条
  • [1] Vitaxin®, an alphav beta3 blocking antibody, inhibits osteoclastic resorption by decreasing the number of attached osteoclasts.
    Gramoun, A
    Manolson, MF
    Heersche, JNM
    Trebec, DP
    Mao, SY
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S154 - S154
  • [2] In vivo migration of radiolabelled lymphocytes in rheumatoid synovial tissue engrafted in SCID mice: Implication of beta 2 and beta 7-integrin
    Jorgensen, C
    Couret, I
    Hellier, I
    Bologna, C
    Canovas, F
    Brochier, J
    Reme, T
    Sany, J
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (01) : 32 - 35
  • [3] CNT0859, a humanized monoclonal anti-tissue factor antibody, inhibits experimental tumor growth in a BxPC-3 human pancreatic adenocarcinoma xenograft tumor model
    Tawadros, R
    Ngo, C
    McCabe, F
    Nakada, M
    Anderson, GM
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S11 - S11
  • [4] A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human alpha v beta 3 (avb3) integrin, ± dacarbazine (DTIC) in patients with metastatic melanoma (MM).
    Hersey, P
    Sosman, J
    O'Day, S
    Richards, J
    Bedikian, A
    Gonzalez, R
    Sharfman, W
    Weber, R
    Logan, T
    Kirkwood, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 711S - 711S
  • [5] A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human alpha v beta 3 (avb3) integrin, ±dacarbazine (DTIC) in patients with metastatic melanoma (MM)
    Hersey, P
    Sosman, J
    O'Day, S
    Richards, J
    Bedikian, A
    Gonzalez, R
    Sharfman, W
    Weber, R
    Logan, T
    Lawson, D
    Zhang, J
    Hammershaimb, L
    Kirkwood, JM
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 643 - 644
1